DOCSLIB.ORG

Melanocytes and Their Diseases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Melanocytes and Their Diseases Downloaded from http://perspectivesinmedicine.cshlp.org/ on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Melanocytes and Their Diseases Yuji Yamaguchi1 and Vincent J. Hearing2 1Medical, AbbVie GK, Mita, Tokyo 108-6302, Japan 2Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Correspondence: [email protected] Human melanocytes are distributed not only in the epidermis and in hair follicles but also in mucosa, cochlea (ear), iris (eye), and mesencephalon (brain) among other tissues. Melano- cytes, which are derived from the neural crest, are unique in that they produce eu-/pheo- melanin pigments in unique membrane-bound organelles termed melanosomes, which can be divided into four stages depending on their degree of maturation. Pigmentation production is determined by three distinct elements: enzymes involved in melanin synthesis, proteins required for melanosome structure, and proteins required for their trafficking and distribution. Many genes are involved in regulating pigmentation at various levels, and mutations in many of them cause pigmentary disorders, which can be classified into three types: hyperpigmen- tation (including melasma), hypopigmentation (including oculocutaneous albinism [OCA]), and mixed hyper-/hypopigmentation (including dyschromatosis symmetrica hereditaria). We briefly review vitiligo as a representative of an acquired hypopigmentation disorder. igments that determine human skin colors somes can be divided into four stages depend- Pinclude melanin, hemoglobin (red), hemo- ing on their degree of maturation. Early mela- siderin (brown), carotene (yellow), and bilin nosomes, especially stage I melanosomes, are (yellow). Among those, melanins play key roles similar to lysosomes whereas late melanosomes in determining human skin (and hair) pigmen- contain a structured matrix and highly dense tation. Melanin pigments can be classified into melanin deposits. Studies of melanosomes are two major types based on their biosynthetic not only performed in medicine but also in ar- pathways, as updated and reviewed elsewhere: chaeology because various morphologies of www.perspectivesinmedicine.org eumelanin (dark brown and black) and pheo- melanosomes remaining in fossils serve as clues melanin (yellow, red, and light brown) (Simon to hypothesize the colors of dinosaurs (Li et al. et al. 2009; Hearing 2011; Kondo and Hearing 2012). 2011). Eu-/pheo-melanin pigments are pro- Melanocytes can be defined as cells that pos- duced and deposited in melanosomes, which sess the unique capacity to synthesize melanins belong to the LRO (lysosome-related organelle) within melanosomes. Factors related to mela- family in that they contain acid-dependent hy- nin production within melanocytes can be di- drolases and lysosomal-associated membrane vided into three groups as previously reviewed: proteins (Raposo and Marks 2007). Melano- structural proteins of melanosomes, enzymes Editors: Anthony E. Oro and Fiona M. Watt Additional Perspectives on The Skin and Its Diseases available at www.perspectivesinmedicine.org Copyright # 2014 Cold Spring Harbor Laboratory Press; all rights reserved; doi: 10.1101/cshperspect.a017046 Cite this article as Cold Spring Harb Perspect Med 2014;4:a017046 1 Downloaded from http://perspectivesinmedicine.cshlp.org/ on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Y. Yamaguchi and V.J. Hearing required for melanin synthesis, and proteins re- Heregulin or Neu differentiation factor) regu- quired for melanosome transport and distribu- lates the survival and proliferation of Schwann tion (Yamaguchi and Hearing 2009). We briefly cell precursors and determines the fate of update the recent findings regarding pigmenta- Schwann cells and melanocytes depending on tion-related factors. high and low expression levels, respectively, Disruptions of the functions of many pig- and that secreted signals, including IGF (insu- mentation-related factors are known to cause lin-like growth factor) and PDGF (platelet-de- pigmentary disorders and a curated list of those rived growth factor) enhance melanocyte devel- aresummarizedandupdated at the homepage of opment (Adameyko et al. 2009). Those findings the European Society for Pigment Cell Research may explain the facts that patients with neurofi- (www.espcr.org/micemut). Those disorders in- bromatosis type 1, who develop neurofibromas clude hyperpigmentation, hypopigmentation, consisting mainly of Schwann cells, are hyper- and mixed hyper-/hypopigmentation disor- pigmented, and that segmental vitiligo mostly ders, which are subdivided into congenital or occurs along with the affected innervation zones acquired status (Table 1). Their diagnosis de- or dermatomes. pends on the size, location (involved site(s) of Taken together, melanocytes in the skin the body), and morphology (isolated, multiple, eventually derive from the neural crest and ei- map-like, reticular, or linear) of the lesions. Hy- ther differentiate directly from neural crest cells popigmentation disorders are subclassified into via a dorsolateral path or derive from Schwann those associated with complete or incomplete cell precursors via a ventral path after detaching depigmentation. from the nerve. Various transcription factors, including Hmx1 and Krox20, act as intrinsic factors that regulate the fate of these cell types, MELANOCYTE DEVELOPMENT which are modulated by extrinsic factors in- As recently summarized (Kawakami and Fisher cluding Neuregulin-1, IGF, and PDGF. 2011; Sommer 2011), melanocytes in the skin are exclusively derived from the neural crest. MELANOCYTE HETEROGENEITY Melanocytes used to be thought to derive di- rectly from neural crest cells migrating via a Human melanocytes reside not only in the epi- dorsolateral path (between the ectoderm and dermis and in hair follicles but also in mucosa, dermamyotome of somites) during embryo- cochlea of the ear, iris of the eye, and mesen- genesis, whereas neurons and glial cells were cephalon of the brain as well as other tissues thought to derive from neural crest cells migrat- (Plonka et al. 2009). As far as mouse melano- www.perspectivesinmedicine.org ing via a ventral path between the neural tube cytes are concerned, Aoki et al. reported that and somites. Adameyko et al. (2009) recently noncutaneous (ear, eye, and harderian gland) challenged this idea and reported that melano- and dermal melanocytes are different from epi- cytes migrate and differentiate from nerve-de- dermal melanocytes in that the former do not rived Schwann cell precursors, whose fate is de- respond to KIT stimulation but respond well to termined by the loss of Hmx1 homeobox gene ET3 (endothelin 3) or HGF (hepatocyte growth function in the ventral path. Schwann cell pre- factor) signals (Aoki et al. 2009), suggesting the cursors detaching from the nerve differentiate heterogeneity of mouse melanocytes. They also into melanocytes, whereas precursors that stay reported that noncutaneous or dermal melano- in contact with nerves eventually differentiate cytes cannot participate in regenerating follicu- into Schwann cells. Those authors also showed lar melanocytes using the hair reconstitution that Schwann cells remain competent to form assay, unlike epidermal melanocytes (Aoki et melanocytes using Krox20 (early growth re- al. 2011). Studies by Tobin’s group also support sponse 2 or Egr2)-Cre loci crossed to YFP re- the hypothesis that follicular and epidermal me- porter strains. They also showed that Neureg- lanocytes in human skin are different regarding ulin-1 (also known as glial growth factor, their responses to various biological response 2 Cite this article as Cold Spring Harb Perspect Med 2014;4:a017046 Downloaded from http://perspectivesinmedicine.cshlp.org/ on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Melanocytes and Their Diseases Table 1. Pigmentary disorders and possible responsive genes Representative disease Disease brief description Locus Mechanism(s) of action Hyperpigmentation disorder Congenital Generalized Widespread lentigines without Chromosome lentiginosis associated noncutaneous 4q21.1-q22.3 abnormalities LEOPARD Multiple lentigines, congenital PTPN11 Protein tyrosine phosphatase, syndrome cardiac abnormalities, ocular nonreceptor type 11 hypertelorism, and retardation of growth Carney complex A multiple neoplasia syndrome PRKAR1A Protein kinase A regulatory characterized by spotty skin subunit 1a pigmentation, cardiac and other myxomas, endocrine tumors, and psammomatous melanotic schwannomas Peutz–Jeghers Pigments on lips and STK11/LKB1 Serine/threonine kinase 11 syndrome palmoplantar area Others Nevus cell nevus, Spitz nevus, Nevus spilus, blue nevus, nevus Ohta, dermal melanosis, nevus Ito, Mongolian spot, ephelides, acropigmentio reticularis, Spitzenpigment/acropigmentation, inherited patterned lentiginosis, Laugier–Hunziker–Baran syndrome, Cronkhite–Canada syndrome Acquired Melasma/chloasma Symmetric malar brownish WIF-1 and Wnt inhibitory factor-1/Wnt and hyperpigmentation others lipid-metabolism-related genes Others Senile lentigines/lentigo, Riehl’s melanosis, labial melanotic macule, penile/vulvovaginal melanosis, erythromelanosis follicularis faciei (Kitamura), pigmentation petaloides actinica tanning, postinflammatory pigmentation, chemical/drug-induced pigmentation, pigmentary demarcation lines, foreign material deposition Hyperpigmentation related with systemic disorders and others Mastocytosis Darier’s sign KIT and others Urticaria
Load more

Recommended publications
  • Uniform Faint Reticulate Pigment Network - a Dermoscopic Hallmark of Nevus Depigmentosus
    Our Dermatology Online Letter to the Editor UUniformniform ffaintaint rreticulateeticulate ppigmentigment nnetworketwork - A ddermoscopicermoscopic hhallmarkallmark ooff nnevusevus ddepigmentosusepigmentosus Surit Malakar1, Samipa Samir Mukherjee2,3, Subrata Malakar3 11st Year Post graduate, Department of Dermatology, SUM Hospital Bhubaneshwar, India, 2Department of Dermatology, Cloud nine Hospital, Bangalore, India, 3Department of Dermatology, Rita Skin Foundation, Kolkata, India Corresponding author: Dr. Samipa Samir Mukherjee, E-mail: [email protected] Sir, ND is a form of cutaneous mosaicism with functionally defective melanocytes and abnormal melanosomes. Nevus depigmentosus (ND) is a localized Histopathologic examination shows normal to hypopigmentation which most of the time is congenital decreased number of melanocytes with S-100 stain and and not uncommonly a diagnostic challenge. ND lesions less reactivity with 3,4-dihydroxyphenylalanine reaction are sometimes difficult to differentiate from other and no melanin incontinence [2]. Electron microscopic hypopigmented lesions like vitiligo, ash leaf macules and findings show stubby dendrites of melanocytes nevus anemicus. Among these naevus depigmentosus containing autophagosomes with aggregates of poses maximum difficulty in differentiating from ash melanosomes. leaf macules because of clinical as well as histological similarities [1]. Although the evolution of newer diagnostic For ease of understanding the pigmentary network techniques like dermoscopy has obviated the
    [Show full text]
  • University of Cincinnati
    UNIVERSITY OF CINCINNATI Date: August 29, 2006 I, Smita Chawla hereby submit this work as a part of the requirements of the degree of: Doctor of Philosophy (Ph. D.) in: Pharmaceutical Sciences It is entitled: Effect of deoxyArbutin and it’s second-generation derivatives on melanocyte viability and function. on Human Nail Permeabili ty . This work and its defense approved by: R. Randall Wickett, Ph.D., Chair Raymond E. Boissy, Ph.D. William Cacini, Ph.D. Prashiela Manga, Ph.D. Marty O. Visscher, Ph.D. EFFECT OF DEOXYARBUTIN AND ITS SECOND-GENERATION DERIVATIVES ON MELANOCYTE VIABILITY AND FUNCTION A dissertation submitted to the Division of Research and Advanced Studies of the University of Cincinnati in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in the Division of Pharmaceutical Sciences of the College of Pharmacy 2006 by Smita Chawla B.S. in Pharmaceutical Sciences Mumbai University, Mumbai, India, 2001 Committee Chair: Randall Wickett, Ph.D. ABSTRACT Therapeutic treatment of skin pigmentary disorders such as melasma, solar lentigines, and post inflammatory hyperpigmentation has been challenging and seldom completely successful. The majority of these therapies target tyrosinase, a key enzyme required for pigment synthesis. The lack of success is due to the less than desired efficacy and safety of tyrosinase inhibitors marketed as skin lightening agents (i.e. hydroquinone, kojic acid and arbutin). We propose that the tyrosinase inhibitor deoxyArbutin (dA) and second-generation derivatives of dA, deoxyFuran, thio-dA, and fluoro-dA, have the potential to be effective inhibitors of skin melanization. In this study, we have analyzed the modulating effects of dA and its derivatives on melanocyte function and viability.
    [Show full text]
  • Skin Pigmentary Variants in Rana Nigromaculata
    Original Article J. Clin. Biochem. Nutr., 38, 195–203, May 2006 Skin Pigmentary Variants in Rana Nigromaculata Ichiro Tazawa, Hitoshi Okumoto, and Akihiko Kashiwagi* Division of Embryology and Genetics, Institute for Amphibian Biology, Graduate School of Science, Hiroshima University, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 739-8526, Japan Received 22 December, 2005; Accepted 26 January, 2006 Summary Because there is mounting evidence to suggest that oxidative stress is involved in the pathophysiology of albinism, albino amphibians are useful tools for studies on imbalances in the oxidant-antioxidant system. In the course of maintaining albino mutant frog strains it was found that crosses between albino males and heterozygous females of Rana nigromaculata sometimes produce offspring displaying pigmentary mosaicism. After hatching hypopigmented portions appear on the left or right side of the body, and this is accompanied by such abnormalities as poor viability, asymmetrical curvature of the body toward the hypopigmented side, and limb deformity. Histological examination of mosaics showed the cells of various tissues (except kidney) to be smaller on the hypopigmented side and larger on the pigmented side compared to corresponding cells in wild type offspring. Cytogenetic analysis of cultured skin cells revealed that wild type and albino individuals were diploidal with 26 chromosomes, the same as normal R. nigromaculata. In mosaics on the other hand, cells of hypopigmented portions were almost exclusively haploidal with 13 chromosomes, while pigmented portions were a mixture of roughly 75% triploidal, 39 chromosome cells and roughly 25% haploidal, 13 chromosome cells. Key Words: albino, unilateral pigmentation, pigmentary mosaicism, chromosomal mosaicism, mixoploidy, haploid, triploid, Rana one means of assessing the involvement of reactive oxygen Introduction species (ROS) in biological processes such as aging.
    [Show full text]
  • EXTENDED CARRIER SCREENING Peace of Mind for Planned Pregnancies
    Focusing on Personalised Medicine EXTENDED CARRIER SCREENING Peace of Mind for Planned Pregnancies Extended carrier screening is an important tool for prospective parents to help them determine their risk of having a child affected with a heritable disease. In many cases, parents aren’t aware they are carriers and have no family history due to the rarity of some diseases in the general population. What is covered by the screening? Genomics For Life offers a comprehensive Extended Carrier Screening test, providing prospective parents with the information they require when planning their pregnancy. Extended Carrier Screening has been shown to detect carriers who would not have been considered candidates for traditional risk- based screening. With a simple mouth swab collection, we are able to test for over 419 genes associated with inherited diseases, including Fragile X Syndrome, Cystic Fibrosis and Spinal Muscular Atrophy. The assay has been developed in conjunction with clinical molecular geneticists, and includes genes listed in the NIH Genetic Test Registry. For a list of genes and disorders covered, please see the reverse of this brochure. If your gene of interest is not covered on our Extended Carrier Screening panel, please contact our friendly team to assist you in finding a gene test panel that suits your needs. Why have Extended Carrier Screening? Extended Carrier Screening prior to pregnancy enables couples to learn about their reproductive risk and consider a complete range of reproductive options, including whether or not to become pregnant, whether to use advanced reproductive technologies, such as preimplantation genetic diagnosis, or to use donor gametes.
    [Show full text]
  • Frequency of Different Types of Facial Melanoses Referring to the Department of Dermatology and Venereology, Nepal Medical Colle
    Amatya et al. BMC Dermatology (2020) 20:4 https://doi.org/10.1186/s12895-020-00100-3 RESEARCH ARTICLE Open Access Frequency of different types of facial melanoses referring to the Department of Dermatology and Venereology, Nepal Medical College and Teaching Hospital in 2019, and assessment of their effect on health-related quality of life Bibush Amatya* , Anil Kumar Jha and Shristi Shrestha Abstract Background: Abnormalities of facial pigmentation, or facial melanoses, are a common presenting complaint in Nepal and are the result of a diverse range of conditions. Objectives: The objective of this study was to determine the frequency, underlying cause and impact on quality of life of facial pigmentary disorders among patients visiting the Department of Dermatology and Venereology, Nepal Medical College and Teaching Hospital (NMCTH) over the course of one year. Methods: This was a cross-sectional study conducted at the Department of Dermatology and Venereology, NMCT H. We recruited patients with facial melanoses above 16 years of age who presented to the outpatient department. Clinical and demographic data were collected and all the enrolled participants completed the validated Nepali version of the Dermatology Life Quality Index (DLQI). Results: Between January 5, 2019 to January 4, 2020, a total of 485 patients were recruited in the study. The most common diagnoses were melasma (166 patients) and post acne hyperpigmentation (71 patients). Quality of life impairment was highest in patients having melasma with steroid induced rosacea-like dermatitis (DLQI = 13.54 ± 1.30), while it was lowest in participants with ephelides (2.45 ± 1.23). Conclusion: Facial melanoses are a common presenting complaint and lead to substantial impacts on quality of life.
    [Show full text]
  • Dermatologic Manifestations of Hermansky-Pudlak Syndrome in Patients with and Without a 16–Base Pair Duplication in the HPS1 Gene
    STUDY Dermatologic Manifestations of Hermansky-Pudlak Syndrome in Patients With and Without a 16–Base Pair Duplication in the HPS1 Gene Jorge Toro, MD; Maria Turner, MD; William A. Gahl, MD, PhD Background: Hermansky-Pudlak syndrome (HPS) con- without the duplication were non–Puerto Rican except sists of oculocutaneous albinism, a platelet storage pool de- 4 from central Puerto Rico. ficiency, and lysosomal accumulation of ceroid lipofuscin. Patients with HPS from northwest Puerto Rico are homozy- Results: Both patients homozygous for the 16-bp du- gous for a 16–base pair (bp) duplication in exon 15 of HPS1, plication and patients without the duplication dis- a gene on chromosome 10q23 known to cause the disorder. played skin color ranging from white to light brown. Pa- tients with the duplication, as well as those lacking the Objective: To determine the dermatologic findings of duplication, had hair color ranging from white to brown patients with HPS. and eye color ranging from blue to brown. New findings in both groups of patients with HPS were melanocytic Design: Survey of inpatients with HPS by physical ex- nevi with dysplastic features, acanthosis nigricans–like amination. lesions in the axilla and neck, and trichomegaly. Eighty percent of patients with the duplication exhibited fea- Setting: National Institutes of Health Clinical Center, tures of solar damage, including multiple freckles, stel- Bethesda, Md (a tertiary referral hospital). late lentigines, actinic keratoses, and, occasionally, basal cell or squamous cell carcinomas. Only 8% of patients Patients: Sixty-five patients aged 3 to 54 years were di- lacking the 16-bp duplication displayed these findings.
    [Show full text]
  • PIGMENT CELL & MELANOMA Research
    The official journal of INTERNATIONAL FEDERATION OF PIGMENT CELL SOCIETIES · SOCIETY FOR MELANOMA RESEARCH PIGMENT CELL & MELANOMA Research Hearing dysfunction in heterozygous Mitf Mi-wh/+ mice, a model for Waardenburg syndrome type 2 and Tietz syndrome Christina Ni, Deming Zhang, Lisa A. Beyer, Karin E. Halsey, Hideto Fukui, Yehoash Raphael, David F. Dolan and Thomas J. Hornyak DOI: 10.1111/pcmr.12030 Volume 26, Issue 1, Pages 78-87 If you wish to order reprints of this article, please see the guidelines here Supporting Information for this article is freely available here EMAIL ALERTS Receive free email alerts and stay up-to-date on what is published in Pigment Cell & Melanoma Research – click here Submit your next paper to PCMR online at http://mc.manuscriptcentral.com/pcmr Subscribe to PCMR and stay up-to-date with the only journal committed to publishing basic research in melanoma and pigment cell biology As a member of the IFPCS or the SMR you automatically get online access to PCMR. Sign up as a member today at www.ifpcs.org or at www.societymelanomaresarch.org To take out a personal subscription, please click here More information about Pigment Cell & Melanoma Research at www.pigment.org Pigment Cell Melanoma Res. 26; 78–87 ORIGINAL ARTICLE Hearing dysfunction in heterozygous Mitf Mi-wh/+ mice, a model for Waardenburg syndrome type 2 and Tietz syndrome Christina Ni1, Deming Zhang1, Lisa A. Beyer2, Karin E. Halsey2, Hideto Fukui2, Yehoash Raphael2, David F. Dolan2 and Thomas J. Hornyak1,3,4 1 Dermatology Branch, Center for Cancer
    [Show full text]
  • Melasma on the Nape of the Neck in a Man
    Letters to the Editor 181 Melasma on the Nape of the Neck in a Man Ann A. Lonsdale-Eccles and J. A. A. Langtry Sunderland Royal Hospital, Kayll Road, Sunderland SR4 7TP, UK. E-mail: [email protected] Accepted July 19, 2004. Sir, sunlight and photosensitizing agents may be more We report a 47-year-old man with light brown macular relevant. pigmentation on the nape of his neck (Fig. 1). It was The differential diagnosis for pigmentation at this site asymptomatic and had developed gradually over 2 years. includes Riehl’s melanosis, Berloque dermatitis and He worked outdoors as a pipe fitter on an oilrig module; poikiloderma of Civatte. Riehl’s melanosis typically however, he denied exposure at this site because he involves the face with a brownish-grey pigmentation; always wore a shirt with a collar that covered the biopsy might be expected to show interface change and affected area. However, on further questioning it liquefaction basal cell degeneration with a moderate transpired that he spent most of the day with his head lymphohistiocytic infiltrate, melanophages and pigmen- bent forward. This reproducibly exposed the area of tary incontinence in the upper dermis. It is usually pigmentation with a sharp cut off inferiorly at the level associated with cosmetic use and may be considered of his collar. He used various shampoos, aftershaves and synonymous with pigmented allergic contact dermatitis shower gels, but none was applied directly to that area. of the face (6, 7). Berloque dermatitis is considered to be His skin was otherwise normal and there was no family caused by a photoirritant reaction to bergapentin; it history of abnormal pigmentation.
    [Show full text]
  • Phacomatosis Spilorosea Versus Phacomatosis Melanorosea
    Acta Dermatovenerologica 2021;30:27-30 Acta Dermatovenerol APA Alpina, Pannonica et Adriatica doi: 10.15570/actaapa.2021.6 Phacomatosis spilorosea versus phacomatosis melanorosea: a critical reappraisal of the worldwide literature with updated classification of phacomatosis pigmentovascularis Daniele Torchia1 ✉ 1Department of Dermatology, James Paget University Hospital, Gorleston-on-Sea, United Kingdom. Abstract Introduction: Phacomatosis pigmentovascularis is a term encompassing a group of disorders characterized by the coexistence of a segmental pigmented nevus of melanocytic origin and segmental capillary nevus. Over the past decades, confusion over the names and definitions of phacomatosis spilorosea, phacomatosis melanorosea, and their defining nevi, as well as of unclassifi- able phacomatosis pigmentovascularis cases, has led to several misplaced diagnoses in published cases. Methods: A systematic and critical review of the worldwide literature on phacomatosis spilorosea and phacomatosis melanorosea was carried out. Results: This study yielded 18 definite instances of phacomatosis spilorosea and 14 of phacomatosis melanorosea, with one and six previously unrecognized cases, respectively. Conclusions: Phacomatosis spilorosea predominantly involves the musculoskeletal system and can be complicated by neuro- logical manifestations. Phacomatosis melanorosea is sometimes associated with ancillary cutaneous lesions, displays a relevant association with vascular malformations of the brain, and in general appears to be a less severe syndrome.
    [Show full text]
  • E S P C R B U L L E T
    E S P C R B U L L E T I N N° 54 April 2006 PUBLISHED BY THE EUROPEAN SOCIETY FOR PIGMENT CELL RESEARCH EDITOR: G. GHANEM (Brussels) INTERNATIONAL F. BEERMANN (Lausanne), J. BOROVANSKY (Prague), M. d’ISCHIA (Naples), JC GARCIA-BORRON (Murcia), , A. NAPOLITANO (Naples), M. PICARDO (Rome), N. SMIT (Leiden). EDITORIAL BOARD: R. MORANDINI (Brussels) Ed Ph In La stitu bor one ito 7. 3. 5. 2. 4. 8. 1. Review oftheliterature communications, ... Discussion, Letterstotheeditor,Reviews,Short CONTENTS Announcements andrelatedactivities 9. Melanomaexperime 6. ria at : t J.Bo 32 ory of Genetics, molecularand Neur Photobiology MSH, MCH,ot Melanosomes Tyrosinase, TRPs,otherenzymes l (DrA.Napolitano) Biology ofpigmentcells Chemistr Office (Dr M.Picardo) (Dr F.Beermann) (Prof JC.Garcia-Borron) - 2 - rdet, Ru 5 Onc 41 omel : .3 G. G o 2. l o 9 e Hég gy a 6 h y ofM a ani F n e n a e m d x: r-Bo Experi (Ed n (DrN.S 3 (Pro s 2 rd (ProfM.d'Ischia) - her hor ito 2 e et 1,B–10 - 5 r) me l a 41 , f J.Bo nt ni C. Meunier .3 al ntal 3. ns andot S 4 m mones u 9 rg 00 developmentalbiology , cellcult it) ery ro and pigmentarydisorders Bru , R. M ( van E-M L s sels, . O (DrR.Morandini) BULLETI R P S E her o .C a r sky i a . Belg l E : ndini g .) pi g ur , h ) ium. Uni a ( e gments n P e versi m ro @ duc u t é l t b Li i on Te .
    [Show full text]
  • Amino Acid Disorders
    471 Review Article on Inborn Errors of Metabolism Page 1 of 10 Amino acid disorders Ermal Aliu1, Shibani Kanungo2, Georgianne L. Arnold1 1Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 2Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA Contributions: (I) Conception and design: S Kanungo, GL Arnold; (II) Administrative support: S Kanungo; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: E Aliu, GL Arnold; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Georgianne L. Arnold, MD. UPMC Children’s Hospital of Pittsburgh, 4401 Penn Avenue, Suite 1200, Pittsburgh, PA 15224, USA. Email: [email protected]. Abstract: Amino acids serve as key building blocks and as an energy source for cell repair, survival, regeneration and growth. Each amino acid has an amino group, a carboxylic acid, and a unique carbon structure. Human utilize 21 different amino acids; most of these can be synthesized endogenously, but 9 are “essential” in that they must be ingested in the diet. In addition to their role as building blocks of protein, amino acids are key energy source (ketogenic, glucogenic or both), are building blocks of Kreb’s (aka TCA) cycle intermediates and other metabolites, and recycled as needed. A metabolic defect in the metabolism of tyrosine (homogentisic acid oxidase deficiency) historically defined Archibald Garrod as key architect in linking biochemistry, genetics and medicine and creation of the term ‘Inborn Error of Metabolism’ (IEM). The key concept of a single gene defect leading to a single enzyme dysfunction, leading to “intoxication” with a precursor in the metabolic pathway was vital to linking genetics and metabolic disorders and developing screening and treatment approaches as described in other chapters in this issue.
    [Show full text]
  • An Unusual Presentation of a Unilateral Asymptomatic Riehl's
    ts & C por a e se R S l Michael, Med Rep Case Stud 2018, 3:1 t a u c d i i DOI: 10.4172/2572-5130.1000152 d e s e M + Medical Reports and Case Studies ISSN: 2572-5130 Case Report Open Access An Unusual Presentation of a Unilateral Asymptomatic Riehl’s Melanosis in a 45 Year Old Male Chan Kam Tim Michael* Department of Dermatology, Hong Kong Academy of Medicine, Hong Kong *Corresponding author: Chan Kam Tim Michael, Department of Dermatology, Hong Kong Academy of Medicine, Hong Kong, Tel: +85221282129; E-mail: [email protected] Received Date: Feb 12, 2018; Accepted Date: Mar 12, 2018; Published Date: Mar 21, 2018 Copyright: © 2018 Michael CKT. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Introduction but of post-inflammatory hyperpigmentation, Acquired unilateral Nevus (Hori’s Nevus), Riehl’s melanosis, Drug-induced Pigmented contact dermatitis (PCD), also known as Riehl’s hyperpigmentation, Lichenoid dermatitis; as well as Melasma and melanosis, is a rare facial hyperpigmentation usually secondary to Ochronosis. cosmetics. There are few documented reports in the literature, and many cases without proven diagnosis may have been treated with pigment lasers, especially in beauty parlour settings. We report a case referred from a private practitioner who has a special interest in dermatology. The patient was diagnosed subsequently as having Riehl’s melanosis and treated with non-tyrosinase inhibitor bleaching agents, sun avoidance and mandatory abstinence from over-the-counter cosmetic products.
    [Show full text]